PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-May-2022 North America, Is The Most Lucrative Market For The Blood Bank Analyzers, Due To The High Number Of Trauma Centers: Fact.MR MARKITWIRED Latest Market Reports
03-May-2022 North America Is Expected To Contribute A Major Revenue Share In The Global Eye Drop Dispenser Market Owing To The Growing Demand For Eye Drop Aids: Fact.MR MARKITWIRED Latest Market Reports
03-May-2022 North America And Europe Radial Access Catheter Market Is Expected To Occupy The Maximum Share Of The Global Radial Access Catheter Market: Fact.MR MARKITWIRED Latest Market Reports
03-May-2022 Inhalational Anaesthesia Drugs Market CAGR is Catching Up the Momentum – Forecast Analysis 2022-2032 MARKITWIRED Latest Market Reports
03-May-2022 Increasing Healthcare Awareness Is Also Expected To Increase The Growth Of The Epinephrine Market: Fact.MR MARKITWIRED Latest Market Reports
03-May-2022 Von Hippel-Lindau Market 2032 Provides Growth Forecast and Upcoming Trends Opportunities by Types, Development Factors MARKITWIRED Latest Market Reports
03-May-2022 Ventricular Restoration Systems Market 2022-2032: Analyzed by Business Growth, Development Factors and Future Prospects MARKITWIRED Latest Market Reports
03-May-2022 Vascular Patches Market 2022-2032 | Country Level Analysis, Current Industry Size and Future Prospective with key vendors, drivers and trends MARKITWIRED Latest Market Reports
03-May-2022 Transesophageal Echocardiography Market 2022: Worldwide Industry Analysis of Development, Revenue and Gross Margin by 2032 MARKITWIRED Latest Market Reports
03-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
03-May-2022 miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test miDiagnostics
03-May-2022 Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults with Neuromyelitis Optica Spectrum Disorder (NMOSD) Horizon Therapeutics
03-May-2022 Publication of Annual Report and Financial Statements for the Year ended 31 December 2021 Acacia Pharma Group
03-May-2022 Coronavirus jams communication signals to immune cells in the gut The Earlham Institute
03-May-2022 Europe’s first dual orexin receptor antagonist – QUVIVIQ (daridorexant) – granted approval to improve both nighttime symptoms and daytime functioning in adults with chronic insomnia disorder Idorsia
03-May-2022 Ipsen: European Commission Approves Cabometyx® as a Second-Line Treatment for People Living With Radioactive Iodine-Refractory Differentiated Thyroid Cancer Businesswire
03-May-2022 Deenova Launches First Ever, Pay-Per-Dose Unit Dose Pharmacy Automation Service in England Businesswire
03-May-2022 AdBio partners welcomes Inserm Transfert as investor in second fund – AFB Fund II Andrew Lloyd Associates
03-May-2022 Ipsen : La Commission européenne approuve Cabometyx® comme traitement de deuxième ligne dans le cancer de la thyroïde différencié réfractaire à l’iode radioactif Businesswire
03-May-2022 Isorg appoints Dieter May as new CEO Andrew Lloyd Associates